呼市哪个医院治痔疮厉害呼和浩特痔疮医院哪家好,呼市水疗医院,呼市哪做痔疮手术比较好,呼和浩特治疗肛肠那个医院好,呼和浩特痔疮医院qq,呼和浩特治痔疮的专业医院,呼和浩特肛裂手术医保报销吗

California will end the cash bail system in a sweeping reform for the state. Rather than requiring defendants to pay in order to be released before trial, their release will hinge on an assessment of their risk to public safety."Today, California reforms its bail system so that rich and poor alike are treated fairly," Gov. Jerry Brown said in a statement.Brown signed the bill Tuesday, and the new law goes into effect October 1, 2019.Critics have long contended that the money bail system perpetuates inequality. While some people are able to quickly get out of jail by posting bail, people who aren't able to afford it sit in jail until the court takes action, or until they work with a bail bond agent to secure their freedom, which can leave them in debt."Abolishing money bail and replacing it with a risk-based system will enhance justice and safety. For too long, our system has allowed the wealthy to purchase their freedom regardless of their risk, while the poor who pose no danger languish in jail," said Assemblymember Rob Bonta, one the lawmakers who introduced the bill, in a statement.Under the new law, a pretrial assessment would be done by either court employees or a local public agency that has been contracted to determine a defendant's risk. That entity would assess the likelihood that the person will not appear in court or commit a new crime while released, and would make a recommendation for conditions of release. The pretrial assessment services will not release a person arrested for violent felonies.The California Money Bail Reform Act, also known as Senate Bill 10, passed in the State Senate with a vote of 26-12, and the General Assembly by 42-31."SB 10 puts all Californians on equal footing before the law and makes public safety the only consideration in pretrial detention. This critical reform is long overdue," Toni Atkins, Senate president pro tempore, said in a statement.But the ACLU in California expressed disappointment over the bill, saying it "is not the model for pretrial justice and racial equity that California should strive for.""It cannot guarantee a substantial reduction in the number of Californians detained while awaiting trial, nor does it sufficiently address racial bias in pretrial decision making," said the three executive directors of the California ACLU affiliates, Abdi Soltani (Northern California), Hector Villagra (Southern California) and Norma Chávez Peterson (San Diego & Imperial Counties). "Indeed, key provisions of the new law create significant new risks and problems."The organization pulled its support for the bill earlier this month as the it underwent changes in the state legislature. 2705

CAPE CORAL, Fla., -- A man accidentally discharged his semiautomatic hand gun Friday while shopping for ammunition inside the retail portion of Shoot Center, a gun store in Cape Coral. "We always assume you have a loaded firearm," said Shoot Center Owner, Aaron Forum, describing store protocol for anyone that pulls out a gun.  Forum took to Facebook to explain the incident:  405

CARLSBAD, Calif. (KGTV) — A North County company is offering one lucky person the chance to pursue their passion without worrying about the funding to start.The contest is being offered by Carlsbad-based apparel company prAna. The company is looking for one person who is willing to quit their day job and pursue their dream, offering the winner 0,000 to begin their new career.“The goal of this promotion is to spread our 'Clothing for Positive Change' philosophy,” said Jeff Haack, vice president of global marketing at prAna. “By asking the question, ‘how can prAna help you affect positive change in your life,' we are giving our audience a means to share their stories about what positive change looks like for them.”Think you are the right fit for the opportunity? To apply, submit a one- to three-minute video between Aug. 15 and Sept. 16 explaining what your current job is and what your dream job would be — the more inspirational the better. Applicants are also encouraged to show their passion in action.Submission will be reviewed based on passion, boldness, and originality. A winner will be selected and asked to quit their job and share updates on their new journey. Funding will then be distributed in four payments.Visit the company's website here to enter your story. 1296

CHAPEL HILL, N.C. - This week, we've heard promises surrounding treatment and vaccines related to COVID-19.Now, doctors at the University of North Carolina (UNC) are using next-generation genetic sequencing of the virus causing COVID-19 that can help testing and therapeutics.Dr. Dirk Dittmer, professor of microbiology and immunology at the UNC School of Medicine, has kept a close eye on COVID-19.“We know now more about this virus than any other virus before,” Dittmer told News 3. “The team has been working 24/7 ever since we had the first cases in March.”He and others are looking at how next-generation genetic sequencing can help with tracking mutations of the virus.“What we were looking at using next-generation technology is if the virus changes, who is the first person that had the virus in North Carolina? And, as we accumulated more and more cases, were these the same types of viruses we're seeing anywhere else in the world,” Dittmer said. “Very early on, we were able to show that one of the mutations that have been around in Europe was actually coming to the U.S.”The state-funded study shows this sequencing can help with the accuracy of diagnostic testing and vaccine effectiveness.“We wanted to make sure that the tests that were developed very early on would still work now and next year. The takeaway is they still work,” he said. “One of the worries that people have is that the virus might change, and therefore, today's vaccine might not work next year.”“Studies like this are part of the ongoing quality control and safety monitoring for vaccines,” Dittmer added.News 3 medical expert Dr. Ryan Light said this sequencing can help in the fight against the virus.“We can tell if it's changed a little bit, we can tell where that virus is coming from,” Light said. “It tells us where the outbreak is coming from, where the danger areas are, and it tells us that our therapies are still working.Meanwhile, Dittmer's lab will continue using this sequencing to track the virus through the end of the year.“We're just a little piece of the puzzle that helps every one to get rid of this thing,” he said.This story was first reported by Zak Dahlheimer at WTKR in Norfolk, Virginia. 2211

Champion is phasing out an exclusive line at Target and Wall Street isn't pleased.Hanesbrands, the parent of Hanes, Champion, Maidenform and Playtex, plunged 19% on Wednesday after it told investors that it would end a longtime deal with Target.The company reported that its profit last quarter fell 18% from the same time last year because costs and expenses both grew, adding to the stock selloff.Hanesbrands has partnered with Target, selling the C9 by Champion men's, women's and children's activewear clothing and shoe brand for 15 years. But the company won't renew its contract for the line with Target when it expires in early 2020.Once the deal lapses, Hanesbrands will still sell clothes there. The retailer accounted for 13% of the company's .4 billion in sales last year and was the biggest customer in its activewear business. Target was Hanesbrands' second largest buyer overall behind Walmart.C9 has been a big cash driver for Hanesbrands, raking in 0 million in sales over the last 12 months. The line also includes sports equipment and extends to plus-size shoppers and pregnant women.Champion is the company's second-largest brand behind Hanes, and it has been growing as it heads to retailers in new markets, including Europe and Asia. Champion has benefited from partnerships with designers and brands like Supreme."Consumers are demanding brands with athletic authenticity," CEO Gerald Evans told analysts on a call Wednesday. "We have driven a brand elevation strategy for Champion to capitalize on these consumer dynamics."The brand's global sales grew 18% last quarter, and Hanesbrands projects Champion will reach more than billion in sales by 2022.Although the company said ending the C9 contract with Target won't affect its long-term forecast for Champion, analysts grilled Hanesbrands executives for answers on why the deal expired and how it planned to replace C9 sales.Evans said Hanesbrands hasn't determined whether it will end the line after 2020, but he left the door open to continuing C9 at another retailer: "There is equity in that brand."One analyst on the call, Doug Thomas at Gamco Investors, believed Target made a mistake by walking away from C9."I just feel like Target must be really out of touch with maybe their core consumers," he said. "This is the time in my view— and I guess a lot of other people's view— to redouble their commitment to Champion." 2416